Limited resection followed by intraoperative seed implantation is comparable to stereotactic body radiotherapy for solitary lung cancer

Cancer

Volumn 116, Issue 21, 2010, Pages 5047-5053

  Parashar, Bhupesh ^a   Patel, Priti ^a   Monni, Stefano ^a   Singh, Prabhsimranjot ^a   Sood, Nikki ^a   Trichter, Samuel ^a   Sabbas, Albert ^a   Wernicke, A Gabriella ^a   Nori, Dattatreyudu ^a   Chao, K S Clifford ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Brachytherapy; Cesium 131; Iodine 125; Lung; Stereotactic

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RADIATION DOSE; RADIOACTIVE SEED IMPLANTATION; RETROSPECTIVE STUDY; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOSURGERY;

EID: 78249234733     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25441     Document Type: Article

References (30)

1. Nakamura H, Kawasaki N, Hagiwara M, et al. Early hilar lung cancer-risk for multiple lung cancers and clinical outcome. Lung Cancer. 2001; 33: 51 -57.
2. Warren W, Faber P,. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. J Thorac Cardiovasc Surg. 1994; 107: 1087 -1094.
3. Ginsberg RJ, Rubinstein LV,. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg. 1995; 60: 615 -621.
4. Kodama K, Doi O, Higashiyama M, et al. Intentional limited resection for selected patients with T1N0M0 nonsmall-cell lung cancer: a single-institution study. J Thorac Cardiovasc Surg. 1997; 114: 347 -353.
5. Yoshikawa K, Tsubota N, Kodama K, et al. Prospective study of extended segmentectomy for small lung tumors: the final report. Ann Thorac Surg. 2002; 73: 1055 -1058.
6. Okada M, Yoshikawa K, Hatta T, et al. Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small lung cancer of 2 cm or smaller? Ann Thorac Surg. 2001; 7: 956 -960.
7. Santos R, Colonias A, Parda D, et al. Comparison between sublobar resection and 125 I brachytherapy following sublobar resection in high-risk patients with stage 1 non-small cell lung cancer. Surgery. 2003; 134: 691 -697.
8. Lee W, Daly BD, DiPetrillo TA, et al. Limited resection for non-small cell lung cancer: observed local recurrence with implantation of I-125 brachytherapy seeds. Ann Thorac Surg. 2003; 75: 237 -242.
9. Shennib H, Bogart JA, Herndon J, et al. Thoracoscopic wedge resection and radiotherapy for T1N0 non-small lung cancer: preliminary analysis of a Cancer and Leukemia Group B and Eastern Oncology Group phase II trial [abstract]. Int J Radiat Oncol Biol Phys. 2000; 48 (3 suppl): 232. Abstract 240.
10. Cackler S, Abbas G,. RFA is an effective alternative to lobectomy for lung cancer. JAAPA. 2009; 22: 25 -28.
11. Blomgren H, Lax I, Naslund I, Svanstrom R,. Stereotactic high dose fraction radiation therapy of extracranial tumours using an accelerator. Acta Oncol. 1995; 34: 861 -870.
12. Powell JW, Dexter E, Scalzetti EM, et al. Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials. Lancet Oncol. 2009; 10: 885 -894.
13. American Association of Physicists in Medicine (AAPM) Radiation Therapy Committee Task Group 43. Dosimetry of Interstitial Brachytherapy Sources: Report TG 43. College Park, Md: AAPM; 1995.
14. Keenan RJ, Landreneau RJ, Maley RH Jr, et al. Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg. 2004; 78: 228.
15. Harada H, Okada M, Sakamoto T, et al. Functional advantage after radical segmentectomy versus lobectomy for lung cancer. Ann Thorac Surg. 2005; 80: 2041 -2045.
16. Yoshimoto K, Nomori H, Mori T, et al. Quantification of the impact of segmentectomy on pulmonary function by perfusion single-photon-emission computed tomography and multidetector computed tomography. J Thorac Cardiovasc Surg. 2009; 137: 1200 -1205.
17. Lafitte JJ, Ribet ME, Prevost BM, et al. Postresection irradiation for T2 N0 M0 non-small cell carcinoma: a prospective, randomized study. Ann Thorac Surg. 1996; 62: 830 -834.
18. Feld R, Rubinstein LV, Weisenberger TH,. Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies. J Clin Oncol. 1984; 2: 1352 -1358.
19. Kato H, Ichinose Y, Ohta M, et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med. 2004; 350: 1713 -1721.
20. Lardinois D, Suter H, Hakki H, et al. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann Thorac Surg. 2005; 80: 268 -274; discussion 274-275.
21. Harpole DH Jr, Herndon JE Jr, Young WG Jr, et al. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence. Cancer. 1995; 76: 787 -796.
22. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg. 1995; 109: 120 -129.
23. Immerman SC, Vanecko RM, Fry WA, et al. Site of recurrence in patients with stages I and II carcinoma of the lung resected for cure. Ann Thorac Surg. 1981; 32: 23 -27.
24. Onishi H, Shirato H, Nagata Y, et al. Hypo-fractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol. 2007; 2: 94 -100.
25. Xiao L, Li Z, Wu L, Sun Z, Yu X,. Sequential treatment of superior vena cava syndrome caused by of non-small cell carcinoma lung cancer (NSCLC) with vascular stenting and iodine-125 implantation. Technol Cancer Res Treat. 2009; 8: 281 -287.
26. Zhang FJ, Li CX, Wu PH, et al. CT guided radioactive 125I seed implantation in treating localized advanced pulmonary carcinoma [in Chinese]. Zhonghua Yi Xue Za Zhi. 2007; 87: 3272 -3275.
27. Trombetta MG, Colonias A, Makishi D, et al. Tolerance of the aorta using intraoperative iodine-125 interstitial brachytherapy in cancer of the lung. Brachytherapy. 2008; 7: 50 -54.
28. Peters N, Wieners G, Pech M, et al. CT-guided interstitial brachytherapy of primary and secondary lung malignancies: results of a prospective phase II trial. Strahlenther Onkol. 2008; 184: 296 -301.
29. Martinez-Monge R, Pagola M, Vivas I, et al. CT-guided permanent brachytherapy for patients with medically inoperable early stage non-small cell lung cancer (NSCLC). Lung Cancer. 2008; 61: 209 -213.
30. McKenna RJ Jr, Mahtabifard A, Yap J, et al. Wedge resection and brachytherapy for lung cancer in patients with poor pulmonary function. Ann Thorac Surg. 2008; 85: S733 -S736.